Literature DB >> 26576416

Corrigendum to "Sensitization of Cancer Cells through Reduction of Total Akt and Downregulation of Salinomycin-Induced pAkt, pGSk3 β , pTSC2, and p4EBP1 by Cotreatment with MK-2206".

Ae-Ran Choi1, Ju-Hwa Kim1, Sungpil Yoon1.   

Abstract

Entities:  

Year:  2015        PMID: 26576416      PMCID: PMC4631851          DOI: 10.1155/2015/138260

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


× No keyword cloud information.
In the paper titled “Sensitization of Cancer Cells through Reduction of Total Akt and Downregulation of Salinomycin-Induced pAkt, pGSk3β, pTSC2, and p4EBP1 by Cotreatment with MK-2206” [1], in the Acknowledgment the funding number “NCC1310120” is wrong and it should be corrected as “NCC1310210.”
  1 in total

1.  Sensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3β, pTSC2, and p4EBP1 by cotreatment with MK-2206.

Authors:  Ae-Ran Choi; Ju-Hwa Kim; Sungpil Yoon
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

  1 in total
  1 in total

1.  Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition.

Authors:  Jun Xing; Vikas Bhuria; Khac Cuong Bui; Mai Ly Thi Nguyen; Zexi Hu; Chih-Jen Hsieh; Kathrin Wittstein; Marc Stadler; Ludwig Wilkens; Jun Li; Markus Kalesse; Przemyslaw Bozko; Ruben R Plentz
Journal:  Cancers (Basel)       Date:  2020-03-06       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.